# KCNT1

## Overview
The KCNT1 gene encodes the potassium sodium-activated channel subfamily T member 1, a protein that functions as a sodium-activated potassium channel, also known as SLACK or Slo2.2. This channel is a critical component of the nervous system, particularly in neurons of the frontal cortex, where it plays a vital role in regulating neuronal excitability and maintaining the resting membrane potential (Rychkov2022Functional; Villa2016Potassium). The KCNT1 protein is characterized by its complex structure, which includes six transmembrane segments and a large intracellular domain, allowing it to form a tetrameric channel that mediates sodium-sensitive potassium currents (Lim2016KCNT1mutations; Cole2021Epilepsycausing). Mutations in the KCNT1 gene are linked to severe neurological disorders, including various forms of epilepsy, due to the channel's role in modulating neuronal firing patterns and excitability (Barcia2012De; Borlot2020KCNT1‐related).

## Structure
The KCNT1 gene encodes a protein that forms part of a potassium channel, specifically the KNa1.1 subunit, which is the largest known potassium channel subunit. This protein is characterized by a complex structure that includes six hydrophobic transmembrane segments (S1-S6) with a pore-loop between S5 and S6, which is crucial for ion selectivity and conduction (Lim2016KCNT1mutations; Cole2021Epilepsycausing). The protein also features a large intracellular carboxy-terminal domain containing tandem regulators of K+ conductance (RCK) domains and an NAD+ binding domain, which are involved in channel regulation (Kaczmarek2013Slack; Lim2016KCNT1mutations).

The KCNT1 protein forms a tetrameric channel, interacting with the KCNT2 protein to mediate a sodium-sensitive potassium current (Lim2016KCNT1mutations). This quaternary structure is essential for its function in neuronal excitability. The protein's structure is similar to the large conductance Ca2+-activated K+ channel (KCa1.1), although it has only about 7% sequence homology (Cole2021Epilepsycausing). The channel is weakly voltage-gated, lacking the positively charged residues typical of voltage-sensitive channels, and its gating likely involves residues near the selectivity filter (Cole2021Epilepsycausing).

In rodents, five distinct Kcnt1 transcripts have been identified, differing at the 5' end, but their existence in humans has not been empirically demonstrated (Lim2016KCNT1mutations).

## Function
The KCNT1 gene encodes a sodium-activated potassium channel, also known as SLACK or Slo2.2, which is highly expressed in the nervous system, particularly in neurons of the frontal cortex (Rychkov2022Functional; Villa2016Potassium). This channel plays a crucial role in regulating neuronal excitability by contributing to the resting membrane potential and hyperpolarization following a train of action potentials (Rychkov2022Functional). In healthy human cells, KCNT1 channels help control the resting membrane potential, regulate membrane resistance, and manage the repolarization rate of action potentials and their frequency (Rychkov2022Functional).

KCNT1 channels are involved in maintaining neuronal excitability and protecting neurons from damage, particularly under ischemic conditions (Barcia2012De). They modulate the firing patterns and general excitability of various neuron types, influencing processes like synaptic transmission and neuronal signaling (Villa2016Potassium; Milligan2014KCNT1). The channel's activity is essential for controlling the excitability of neurons, which is critical for normal brain function (Rychkov2022Functional). The KCNT1 protein interacts with a network of proteins, including the Fragile-X Mental Retardation Protein (FMRP), which stimulates its activity (Barcia2012De).

## Clinical Significance
Mutations in the KCNT1 gene are associated with a range of severe neurological disorders, primarily characterized by epilepsy. Gain-of-function mutations in KCNT1 lead to constitutive hyperactivation of the potassium channel, which is implicated in several epileptic encephalopathies. One of the most severe conditions linked to KCNT1 mutations is malignant migrating partial seizures of infancy (MMPSI), characterized by pharmacoresistant seizures and significant developmental delays (Barcia2012De). These mutations are often de novo and result in increased current amplitude, locking the channel into a constitutively activated state (Barcia2012De).

KCNT1 mutations are also associated with epilepsy of infancy with migrating focal seizures (EIMFS), which involves early-onset refractory seizures and severe developmental impairments (Barcia2019Epilepsy; Borlot2020KCNT1‐related). Other conditions linked to KCNT1 include autosomal dominant sleep-related hypermotor epilepsy (ADSHE) and status dystonicus, both of which involve motor seizures and cognitive disabilities (Gertler2019Functional; Cole2021Targeting).

The phenotypic spectrum of KCNT1-related disorders is broad, with significant variability in clinical presentation even among individuals with the same mutation (Borlot2020KCNT1‐related). Despite the identification of KCNT1 mutations, effective treatment remains challenging, with therapies like quinidine showing inconsistent clinical efficacy (Milligan2014KCNT1).

## Interactions
KCNT1, which encodes the potassium sodium-activated channel subfamily T member 1, is involved in several protein interactions that influence neuronal excitability and synaptic transmission. One significant interaction is with the Fragile X Mental Retardation Protein (FMRP), which regulates neuronal protein synthesis. FMRP binding increases the open probability of the Slack channel, encoded by KCNT1, thereby enhancing its activity. The absence of FMRP is associated with Fragile X syndrome, characterized by intellectual disability and seizures, highlighting the importance of this interaction (Cole2021Targeting; Quraishi2020Impaired).

KCNT1 also interacts with other ion channels, such as KCNT2, forming heteromers that can alter the biophysical properties of the channel. This interaction may protect certain neuron types, like glutamatergic neurons, from the severe effects of KCNT1 gain-of-function mutations (Shore2020Reduced). Additionally, KCNT1's interaction with Phactr1, a protein that suppresses channel activity, is disrupted by pathogenic variants, suggesting a potential therapeutic target for KCNT1-related epilepsy (Cole2021Targeting). These interactions are crucial for maintaining normal brain function and preventing epileptic activity, as they modulate the channel's activity and influence neuronal network dynamics.


## References


[1. (Villa2016Potassium) Chiara Villa and Romina Combi. Potassium channels and human epileptic phenotypes: an updated overview. Frontiers in Cellular Neuroscience, March 2016. URL: http://dx.doi.org/10.3389/fncel.2016.00081, doi:10.3389/fncel.2016.00081. This article has 102 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2016.00081)

[2. (Borlot2020KCNT1‐related) Felippe Borlot, Ahmed Abushama, Nadine Morrison‐Levy, Puneet Jain, Kollencheri Puthenveettil Vinayan, Musaad Abukhalid, Hesham M. Aldhalaan, Hanin S. Almuzaini, Sheffali Gulati, Tova Hershkovitz, Ramesh Konanki, Lokesh Lingappa, Aimee F. Luat, Shatha Shafi, Brahim Tabarki, Maya Thomas, Sangeetha Yoganathan, Majid Alfadhel, Ravindra Arya, Elizabeth J. Donner, Salleh N. Ehaideb, Vykuntaraju K. Gowda, Vivek Jain, Priyanka Madaan, Kenneth A. Myers, Hiroshi Otsubo, Prateek Panda, Jitendra K. Sahu, Letícia P. B. Sampaio, Suvasini Sharma, Elisabeth Simard‐Tremblay, Maria Zak, and Robyn Whitney. Kcnt1‐related epilepsy: an international multicenter cohort of 27 pediatric cases. Epilepsia, 61(4):679–692, March 2020. URL: http://dx.doi.org/10.1111/epi.16480, doi:10.1111/epi.16480. This article has 52 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/epi.16480)

[3. (Shore2020Reduced) Amy N. Shore, Sophie Colombo, William F. Tobin, Sabrina Petri, Erin R. Cullen, Soledad Dominguez, Christopher D. Bostick, Michael A. Beaumont, Damian Williams, Dion Khodagholy, Mu Yang, Cathleen M. Lutz, Yueqing Peng, Jennifer N. Gelinas, David B. Goldstein, Michael J. Boland, Wayne N. Frankel, and Matthew C. Weston. Reduced gabaergic neuron excitability, altered synaptic connectivity, and seizures in a kcnt1 gain-of-function mouse model of childhood epilepsy. Cell Reports, 33(4):108303, October 2020. URL: http://dx.doi.org/10.1016/j.celrep.2020.108303, doi:10.1016/j.celrep.2020.108303. This article has 52 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2020.108303)

[4. (Barcia2012De) Giulia Barcia, Matthew R Fleming, Aline Deligniere, Valeswara-Rao Gazula, Maile R Brown, Maeva Langouet, Haijun Chen, Jack Kronengold, Avinash Abhyankar, Roberta Cilio, Patrick Nitschke, Anna Kaminska, Nathalie Boddaert, Jean-Laurent Casanova, Isabelle Desguerre, Arnold Munnich, Olivier Dulac, Leonard K Kaczmarek, Laurence Colleaux, and Rima Nabbout. De novo gain-of-function kcnt1 channel mutations cause malignant migrating partial seizures of infancy. Nature Genetics, 44(11):1255–1259, October 2012. URL: http://dx.doi.org/10.1038/ng.2441, doi:10.1038/ng.2441. This article has 394 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.2441)

[5. (Rychkov2022Functional) Grigori Y. Rychkov, Zeeshan Shaukat, Chiao Xin Lim, Rashid Hussain, Ben J. Roberts, Claudia M. Bonardi, Guido Rubboli, Brandon F. Meaney, Robyn Whitney, Rikke S. Møller, Michael G. Ricos, and Leanne M. Dibbens. Functional effects of epilepsy associated kcnt1 mutations suggest pathogenesis via aberrant inhibitory neuronal activity. International Journal of Molecular Sciences, 23(23):15133, December 2022. URL: http://dx.doi.org/10.3390/ijms232315133, doi:10.3390/ijms232315133. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms232315133)

[6. (Kaczmarek2013Slack) Leonard K. Kaczmarek. Slack, slick, and sodium-activated potassium channels. ISRN Neuroscience, 2013:1–14, May 2013. URL: http://dx.doi.org/10.1155/2013/354262, doi:10.1155/2013/354262. This article has 105 citations.](https://doi.org/10.1155/2013/354262)

[7. (Lim2016KCNT1mutations) Chiao Xin Lim, Michael G Ricos, Leanne M Dibbens, and Sarah E Heron. Kcnt1mutations in seizure disorders: the phenotypic spectrum and functional effects. Journal of Medical Genetics, 53(4):217–225, January 2016. URL: http://dx.doi.org/10.1136/jmedgenet-2015-103508, doi:10.1136/jmedgenet-2015-103508. This article has 90 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmedgenet-2015-103508)

[8. (Gertler2019Functional) Tracy S. Gertler, Christopher H. Thompson, Carlos G. Vanoye, John J. Millichap, and Alfred L. George. Functional consequences of a kcnt1 variant associated with status dystonicus and early‐onset infantile encephalopathy. Annals of Clinical and Translational Neurology, 6(9):1606–1615, July 2019. URL: http://dx.doi.org/10.1002/acn3.50847, doi:10.1002/acn3.50847. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/acn3.50847)

9. (Cole2021Epilepsycausing) Epilepsy-causing KCNT1 variants increase KNa1.1 channel activity by disrupting the activation gate. This article has 5 citations.

[10. (Barcia2019Epilepsy) Giulia Barcia, Nicole Chemaly, Mathieu Kuchenbuch, Monika Eisermann, Stéphanie Gobin-Limballe, Viorica Ciorna, Alfons Macaya, Laetitia Lambert, Fanny Dubois, Diane Doummar, Thierry Billette de Villemeur, Nathalie Villeneuve, Marie-Anne Barthez, Caroline Nava, Nathalie Boddaert, Anna Kaminska, Nadia Bahi-Buisson, Mathieu Milh, Stéphane Auvin, Jean-Paul Bonnefont, and Rima Nabbout. Epilepsy with migrating focal seizures: kcnt1 mutation hotspots and phenotype variability. Neurology Genetics, December 2019. URL: http://dx.doi.org/10.1212/NXG.0000000000000363, doi:10.1212/nxg.0000000000000363. This article has 39 citations.](https://doi.org/10.1212/NXG.0000000000000363)

[11. (Cole2021Targeting) Bethan A. Cole, Steven J. Clapcote, Stephen P. Muench, and Jonathan D. Lippiat. Targeting kna1.1 channels in kcnt1-associated epilepsy. Trends in Pharmacological Sciences, 42(8):700–713, August 2021. URL: http://dx.doi.org/10.1016/j.tips.2021.05.003, doi:10.1016/j.tips.2021.05.003. This article has 27 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.tips.2021.05.003)

[12. (Milligan2014KCNT1) Carol J. Milligan, Melody Li, Elena V. Gazina, Sarah E. Heron, Umesh Nair, Chantel Trager, Christopher A. Reid, Anu Venkat, Donald P. Younkin, Dennis J. Dlugos, Slavé Petrovski, David B. Goldstein, Leanne M. Dibbens, Ingrid E. Scheffer, Samuel F. Berkovic, and Steven Petrou. Kcnt1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Annals of Neurology, 75(4):581–590, April 2014. URL: http://dx.doi.org/10.1002/ana.24128, doi:10.1002/ana.24128. This article has 225 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.24128)

[13. (Quraishi2020Impaired) Imran H. Quraishi, Michael R. Mercier, Heather McClure, Rachael L. Couture, Michael L. Schwartz, Robert Lukowski, Peter Ruth, and Leonard K. Kaczmarek. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the kcnt1 gene encoding slack (kna1.1) na+-activated k+ channels. Scientific Reports, February 2020. URL: http://dx.doi.org/10.1038/s41598-020-60028-z, doi:10.1038/s41598-020-60028-z. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-60028-z)